1. Home
  2. CTSO vs SNSC Comparison

CTSO vs SNSC Comparison

Compare CTSO & SNSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

N/A

Current Price

$5.60

Market Cap

23.9M

Sector

Health Care

ML Signal

N/A

SNSC

SunScout Holding Limited Class A Ordinary Shares

N/A

Current Price

$0.74

Market Cap

26.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CTSO
SNSC
Founded
1997
1998
Country
United States
New Zealand
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.9M
26.9M
IPO Year
2008
2026

Fundamental Metrics

Financial Performance
Metric
CTSO
SNSC
Price
$5.60
$0.74
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $12.25
N/A
AVG Volume (30 Days)
★ 63.7K
60.2K
Earning Date
11-12-2026
11-23-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 65.79
N/A
EPS
N/A
★ N/A
Revenue
★ $22,503,908.00
N/A
Revenue This Year
$4.91
N/A
Revenue Next Year
$13.58
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 48.53
N/A
52 Week Low
$0.30
$0.21
52 Week High
$7.44
$3.15

Technical Indicators

Market Signals
Indicator
CTSO
SNSC
Relative Strength Index (RSI) 60.92 34.99
Support Level $2.88 $0.63
Resistance Level $7.20 $1.10
Average True Range (ATR) 0.71 0.18
MACD 0.09 0.01
Stochastic Oscillator 81.26 57.10

Price Performance

Historical Comparison
CTSO
SNSC

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

About SNSC SunScout Holding Limited Class A Ordinary Shares

SunScout Holding Ltd is a clean-technology company engaged in the design, development, manufacturing, and commercialization of autonomous, solar-powered robotic mowers and related solar energy solutions. Its products are intended as alternatives to petrol-powered and grid-dependent electric lawn mowing equipment. The company's business comprises three lines of products and solutions, which are also its reportable segments: SunScout Products, Solar Power Development Solutions, and Engineering Products and Services. The majority of revenue is derived from the Solar Power Development Solutions segment, which develops and installs solar-energy systems for commercial, industrial, and institutional customers through EPC contracts. Geographically, maximum revenue is derived from New Zealand.

Share on Social Networks: